摘要:
The present disclosure provides a multi-edge saw blade for use with an oscillating tool that provides multiple cutting edges that can be used sequentially as each cutting edge becomes worn-out or damaged. The multi-edge saw blade includes a first row of cutting teeth arranged across its distal edge and a row of perforations situated across the distal end of the blade and spaced a distance behind the first row of cutting teeth. In some aspects, the multi-edge saw blade further includes at least one additional row of perforations, each situated a spaced distance behind the row of perforations before it. Responsive to a twisting force applied orthogonally to the plane of the blade, each blade edge can be removed from the blade to reveal a fresh row of cutting teeth. The multi-edge saw blade further includes an attachment socket on its proximate end.
摘要:
A fifth wheel lubricant applicator tool, kit, and method of use are disclosed. The lubricant applicator tool comprises a handle portion and an operative portion. The handle portion has a first width and a defined length. The operative portion extends out from the defined length of the handle portion such that a second width of the operative portion remains less than a length of the lubricant applicator tool. The operative portion comprises a working edge equipped with a plurality of indentations that are identical and evenly spaced. The width and the height of each of the plurality of indentations permits an application of a lubricant in parallel beads, each spaced apart from adjacent beads by a defined distance that is substantially same as a distance between two adjacent indentations.
摘要:
The invention relates to a humanized form of an antibody capable of preventing tissue factor (coagulation factor F3) signaling but which does not interfere with Factor VII binding or FX binding to tissue factor and does not prolong coagulation time. The antibody of the invention is useful in treating conditions, such as tumor progression, in which the associated cells express tissue factor and tissue factor signaling occurs.
摘要:
The present disclosure relates to a combination of therapeutic agents for use in treating a patient a subject suffering from cancer. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
摘要:
A method and a system perform geolocation activities relating to a network address. A database of network addresses, and associated geographic locations, is maintained. A query, including a network address, is received against the database for a geographic location associated with the network address. Information, concerning the query received against the database, is logged. Geolocation activities relating to at least the network address are modified based on the logged information.
摘要:
Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.
摘要:
The present invention provides a method for treating structural heart disease in a subject, comprising administering an effective amount of an inhibitor of CaMKII to the subject, whereby the administration of the inhibitor treats the structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease.
摘要:
A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in FIG. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of obesity or diabetes. Methods for using the pharmaceutical compositions also are described. In these methods, various diseases are treated or other body functions are activated or inhibited by administering an effective amount of the pharmaceutical composition. For example, diabetes and obesity may be treated by administering an effective amount of the pharmaceutical compositions. Weight gain, and growth factor production can be inhibited by administering an effective amount of these pharmaceutical compositions. Appetite can be suppressed by administering an effective amount of the pharmaceutical compositions, and a diuretic effect can be produced.
摘要:
An integrated circuit interconnect is fabricated by using a mask to form a via in an insulating layer for a conductive plug. After the plug is formed in the via, a thin (e.g.,
摘要:
The present invention provides a method for treating structural heart disease in a subject, comprising administering an effective amount of an inhibitor of CaMKII to the subject, whereby the administration of the inhibitor treats the structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease.